972 related articles for article (PubMed ID: 15375007)
1. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
2. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
[TBL] [Abstract][Full Text] [Related]
3. [Effects of recombinant human morphogenetic protein-2 on pulmonary artery pressure in acute lung injury caused by endotoxin and mechanism thereof: experiment with rats].
Shan SM; Pei L; Wang JK
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3201-6. PubMed ID: 17313787
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN
Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647
[TBL] [Abstract][Full Text] [Related]
5. Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.
Michelakis ED; McMurtry MS; Wu XC; Dyck JR; Moudgil R; Hopkins TA; Lopaschuk GD; Puttagunta L; Waite R; Archer SL
Circulation; 2002 Jan; 105(2):244-50. PubMed ID: 11790708
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats.
Zhai FG; Zhang XH; Wang HL
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):850-6. PubMed ID: 19298536
[TBL] [Abstract][Full Text] [Related]
7. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells.
Archer SL; Wu XC; Thébaud B; Nsair A; Bonnet S; Tyrrell B; McMurtry MS; Hashimoto K; Harry G; Michelakis ED
Circ Res; 2004 Aug; 95(3):308-18. PubMed ID: 15217912
[TBL] [Abstract][Full Text] [Related]
8. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
9. Effect of mitochondrial KATP channel on voltage-gated K+ channel in 24 hour-hypoxic human pulmonary artery smooth muscle cells.
Wang T; Zhang ZX; Xu YJ
Chin Med J (Engl); 2005 Jan; 118(1):12-9. PubMed ID: 15642220
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
11. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
12. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension.
Merklinger SL; Jones PL; Martinez EC; Rabinovitch M
Circulation; 2005 Jul; 112(3):423-31. PubMed ID: 16027270
[TBL] [Abstract][Full Text] [Related]
14. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
Dumas de la Roque E; Savineau JP; Bonnet S
Pharmacol Ther; 2010 May; 126(2):186-99. PubMed ID: 20206649
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
McMurtry MS; Archer SL; Altieri DC; Bonnet S; Haromy A; Harry G; Bonnet S; Puttagunta L; Michelakis ED
J Clin Invest; 2005 Jun; 115(6):1479-91. PubMed ID: 15931388
[TBL] [Abstract][Full Text] [Related]
17. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
[TBL] [Abstract][Full Text] [Related]
19. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling.
Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]